Stay updated with breaking news from Quantum Genomics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release Paris, November 25, 2021 Quantum Genomics signs an exclusive license agreement with Teva Israel Ltd. Quantum Genomics will receive up to $11 M in payments and 25% minimum up to 30%
Press release Paris, November 23, 2021 Dr. Catherine Llorens-Cortes receives the 2021 Emilia Valori Prize from the French Academy of Sciences Quantum Genomics (Euronext Growth: ALQGC, OTCQX: QNNTF)
Quantum Genomics and its partners reach a new stage of development in Asia The phase III REFRESH study has been approved by the regulatory authorities and ethics committees in South Korea and Taiwan. Pre-marketing
Quantum Genomics Publishes 2021 Half-year Results and Reviews its Clinical Activity Firibastat expected to launch in late 2023 for difficult-to-treat/resistant hypertension. Gross cash of €24.9
Quantum Genomics Publishes 2021 Half-year Results and Reviews its Clinical Activity Firibastat expected to launch in late 2023 for difficult-to-treat/resistant hypertension. Gross cash... | October 6, 2021